Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-12-000348
Filing Date
2012-07-18
Accepted
2012-07-18 20:08:19
Documents
1
Period of Report
2012-07-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5591
  Complete submission text file 0000904454-12-000348.txt   6966
Mailing Address ONE PALMER SQUARE PRINCETON NJ 08542
Business Address
SCHOEMAKER KATHLEEN K (Reporting) CIK: 0001207789 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35599 | Film No.: 12968847

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations